Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas
Yinglu Li, Elizabeth M. Goldberg, Xiao Chen, et al.
Molecular Cell (2022) Vol. 82, Iss. 20, pp. 3901-3918.e7
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 78
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 51
Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics
Fengyun Zhong, Yilin Lin, Long Zhao, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 24-37
Open Access | Times Cited: 32
Targeting methionine metabolism in cancer: opportunities and challenges
Peng Bin, Chuanlong Wang, Hangchao Zhang, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 395-405
Closed Access | Times Cited: 15
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling
Alison A. Chomiak, Rochelle L. Tiedemann, Yanqing Liu, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 9
Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy
Brian S. Henick, Alison Taylor, Hiroshi Nakagawa, et al.
Cancer Cell (2025) Vol. 43, Iss. 2, pp. 178-194
Closed Access | Times Cited: 1
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
Yingying Gong, Lisha Bao, Tong Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 18
Mechanisms of DNA Methylation Regulatory Function and Crosstalk with Histone Lysine Methylation
Bailey M. Tibben, Scott B. Rothbart
Journal of Molecular Biology (2023) Vol. 436, Iss. 7, pp. 168394-168394
Closed Access | Times Cited: 18
Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8
Head and neck cancer: pathogenesis and targeted therapy
Yan Liu, Nannan Zhang, Yi Wen, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 7
NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma
Iuliia Topchu, Igor Bychkov, Demirkan Gursel, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Epigenetic regulation of macrophage function in kidney disease: New perspective on the interaction between epigenetics and immune modulation
Ruizhi Tan, Qianrong Bai, Lingfei Jia, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117842-117842
Closed Access
Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect
Chou‐Yi Hsu, Ahmed Mohammed, Ahmed Hjazi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Copper-based metal–organic frameworks for antitumor application
Yangwei Qian, Chenxi Wang, Risheng Xu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Comprehensive Analysis of Multi-Omics Data on RNA Polymerase as an Adverse Factor in Head and Neck Squamous Cell Carcinoma
Yue Gu, Jie Zhang, Yuan-jie Liu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 3067-3091
Open Access
Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma
Brandon Ramchatesingh, Amelia Martínez Villarreal, Philippe Lefrançois, et al.
Molecular Oncology (2025)
Open Access
The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts
Xiaoqiang Wang, Jiaxing Jin, Han Yan, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 793
Closed Access
ISG20 stimulates anti-tumor immunity via a double-stranded RNA-induced interferon response in ovarian cancer
Zhigao Chen, Min Yin, Haixue Jia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Integrative multi-omics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities
Pengfei Diao, Yibin Dai, An Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 3101-3117
Closed Access | Times Cited: 3
Cross-Regulation Between Redox and Epigenetic Systems in Tumorigenesis: Molecular Mechanisms and Clinical Applications
Xiao Zhang, Lifang Ma, Jiayi Wang
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 7-9, pp. 445-471
Closed Access | Times Cited: 7
Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma
Yuxi Cheng, Zhengzheng Song, Xiaodan Fang, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Histone modifications in head and neck squamous cell carcinoma
Wei Mao, Baoxin Wang, Ruofei Huang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top